Regulatory submissions demand more than analysis, they require clear, credible evidence to support dosing, labeling, and decision-making.
At Certara, multidisciplinary teams of clinical pharmacologists, biostatisticians, and modelers work together to deliver submission-ready pharmacometrics analyses aligned with global regulatory expectations. Using rigorous population PK and exposure–response modeling, we characterize variability, justify dose selection, and clearly communicate benefit–risk.
This model-informed approach ensures analyses are scientifically robust and designed to withstand regulatory scrutiny, supporting smoother interactions, more efficient submissions, and confident decisions across NDA, BLA, and MAA filings.
